The biotechnology industry in Latin America is rapidly evolving, fueled by increased investment and innovation. It encompasses a range of companies developing solutions in areas such as healthcare, agriculture, and environmental sustainability. Startups and established firms work on cutting-edge projects, including gene editing, biopharmaceuticals, and agricultural biotechnology. The industry is gaining momentum, with partnerships forming across borders, leveraging knowledge and resources to drive breakthroughs. Growing interest in health and sustainable farming is pushing the industry towards global competitiveness, creating opportunities for local talent and foreign investment in a bright future.

The list of biotechnology investors in this article includes 18 prominent firms primarily based in Brazil, Argentina, and Chile. Most of these firms are venture capitalists, focusing on early to mid-stage startups. Their headcounts range from small, nimble teams to larger organizations. Investors like Bossa Invest and Eretz.bio, founded between 2011 and 2021, have made significant contributions to the biotech landscape with 2024 deals ranging from single investments to numerous funding rounds. This active participation underscores the robust growth potential of biotechnology in the region.

Top 18 Biotechnology Investors in Latin America

1. bossa invest

• Website: bossainvest.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn: bossainvest

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in the technology sector, and has a strong focus on supporting entrepreneurs through capital, strategic guidance, and access to a network of co-investors. In the biotechnology space, Bossa Invest has been involved in notable transactions, including participating in funding rounds for Caribou Biosciences, which raised significant capital to advance its CRISPR technology platform, and Alloy Therapeutics, which focuses on developing therapeutic solutions. These investments highlight Bossa Invest's commitment to fostering growth in the biotechnology industry alongside its broader technology investment strategy.

2. Eretz.bio

• Website: eretz.bio
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn: eretz.bio

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It operates as an innovation hub associated with the Hospital Israelita Albert Einstein, focusing on incubating startups in the healthcare sector. Eretz.bio provides resources and support to develop innovative solutions in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been actively involved in funding several biotechnology startups, including Speratum Biopharma, Inc., which raised funds in a venture round, and multiple seed rounds for companies like RadBio and Oncobiomed. These transactions highlight Eretz.bio's commitment to fostering innovation in the biotechnology space.

3. GRIDS Capital

• Website: gridscapital.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn: grids-capital

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, they have participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million in a Series B round to enhance its AI/ML-wet lab platform and advance therapeutic programs. They also invested in Senti Biosciences during its Series A round and have been involved with Fauna Bio in its Seed Round. These transactions highlight GRIDS Capital's active role in the biotechnology sector, particularly in companies that are at the intersection of technology and life sciences.

4. The Ganesha Lab

• Website: theganeshalab.com
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn: ganeshalab

The Ganesha Lab is a corporate biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. They focus on supporting early-stage biotech startups in Latin America through various programs, including BIGinBIO and Scale Up. The Ganesha Lab provides essential resources such as mentorship, workshops, and access to funding, helping startups navigate the complexities of the biotech industry and scale their innovations for global impact. Notable transactions include their investment in Botanical Solutions, which raised $3.3 million in a seed round in December 2020, and their involvement with Pannex Therapeutics Inc., which raised an undisclosed amount in a pre-seed round in January 2021. These transactions highlight their active role in fostering biotech innovation.

5. Cites

• Website: cites-gss.com
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn: cites

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting the development of scientific and technological startups, providing not only venture capital investment but also mentorship and access to essential resources. Cites has been involved in several notable transactions within the biotechnology sector, including investments in RadBio and ARDAN PHARMA, both of which raised funds in seed rounds. In 2022, they invested $600,000 in Limay Biosciences, further demonstrating their commitment to biotechnology. Additionally, Cites co-led a $2.7 million Series A investment in Eolo Pharma, a clinical research startup focused on developing anti-obesity drugs, highlighting their active role in advancing biotechnology innovations. Their portfolio reflects a strong emphasis on early-stage companies aiming to transform innovative ideas into successful businesses in the biotechnology field.

6. AIR Capital

• Website: aircapital.vc
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn: air-capital-vc

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital provides both investment and consulting services, leveraging insights from their extensive experience in the technology sector. Their portfolio includes a diverse range of startups across various industries, with a notable emphasis on biotechnology. Among their relevant transactions, AIR Capital has invested in Tissue Dynamics and Aplife Biotech, both of which are involved in the biotechnology sector. In 2024, they participated in funding rounds for Oncoliq, a company likely focused on biotechnological advancements. Additionally, their investment in Puna Bio, which is developing agricultural biotechnology solutions, highlights their commitment to fostering innovation in the biotechnology space.

7. SP Ventures

• Website: spventures.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn: sp-ventures

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for the agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help them innovate and grow. Notably, SP Ventures has been involved in several transactions that highlight their engagement with biotechnology. For instance, they invested in Decoy Smart Control, which raised $2 million to develop biological controls for pests affecting farm animals, showcasing their commitment to biotechnology in agriculture. Additionally, their investment in Gênica, which raised $5.7 million in 2022, further emphasizes their focus on innovative biotech solutions within the AgFood value chain. Overall, SP Ventures is positioned as a key player in the intersection of agriculture and biotechnology.

8. Zentynel Frontier Investments

• Website: zentynel.com
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn: zentynel-frontier-investments

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative biotechnology startups. Zentynel focuses on high-growth potential companies, helping them navigate the challenges of funding and market entry. Notable transactions include leading a $10 million Series A-1 financing for Autem Therapeutics, which is developing a bioelectric oncology treatment platform targeting solid tumors. They also participated in seed funding rounds for Xeptiva Therapeutics, which raised $2.5 million, and MultiplAI Health, a diagnostics company that secured $2.7 million in seed funding. These investments highlight Zentynel's active role in supporting the biotechnology sector and its commitment to fostering innovation in this field.

9. Kptl

• Website: kptl.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn: inseed-investimentos

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in the investment sector, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Notably, KPTL has shown a strong interest in biotechnology, having participated in several significant transactions. For instance, they invested in Omics Animal Biotechnology in 2023, Celer Biotecnologia in 2008, Vida Biotecnologia in 2012, and Akmey Biotecnologia Têxtil in 2015. These investments highlight KPTL's commitment to supporting the growth of biotechnology companies, providing both capital and strategic guidance to help them succeed in their respective markets.

10. IKJ Capital

• Website: ikj.capital
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn: irukandji-capital

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in early-stage investments in healthcare technology companies, focusing on addressing significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been active in the investment landscape, participating in several funding rounds. Notably, they invested in Shift Bioscience, which raised over $16 million in a Seed Round, indicating a strong commitment to biotechnology and innovative health solutions. Other investments include Portal, which raised $7 million in a Seed Round, and Earli, which secured funding in a Venture Round. These transactions highlight IKJ Capital's dedication to supporting startups that are developing impactful healthcare technologies, including those in the biotechnology sector.

11. The Yield Lab LATAM

• Website: theyieldlablatam.com
• Type: Venture Capital
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn: theyieldlablatam

The Yield Lab LATAM is a venture capital firm based in Buenos Aires, Argentina, founded in 2017. It specializes in the AgriFoodTech sector, investing in early-stage startups that tackle challenges within the agri-food industry. The firm not only provides capital but also supports its portfolio companies through governance, talent development, and fundraising assistance. Notably, The Yield Lab LATAM has been involved in several transactions relevant to biotechnology, including investments in Botanical Solutions, which focuses on botanical-based products, and Symbiomics, which is engaged in microbiome research. These investments highlight the firm's commitment to fostering innovation that may leverage biotechnological advancements to improve agricultural practices and food production.

12. Clave Capital

• Website: clavecapital.com.br
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: clavecapital

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, the firm manages various funds focused on equity, credit, and real estate investments. Clave Capital has recently made significant strides in the biotechnology sector, participating in funding rounds for innovative companies such as OneChain Immunotherapeutics, which is developing CAR-T therapies, and ADmit Therapeutics, which is working on solutions for Alzheimer's disease. Their involvement in these transactions highlights their commitment to supporting the biotechnology industry and helping to bring novel therapies to market. Clave Capital operates with a disciplined approach to capital allocation, aiming to achieve financial growth for its clients, which include both businesses and individual investors.

13. Draper Cygnus

• Website: drapercygnus.vc
• Type: Venture Capital
• Headquarters: Lomas Del Mirador, Buenos Aires, Argentina
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn: drapercygnus

Draper Cygnus is a venture capital firm based in Lomas Del Mirador, Buenos Aires, Argentina, founded in 2017. The firm specializes in investing in deep-tech startups founded by Latino entrepreneurs, providing both funding and support to help these companies develop innovative technologies across various sectors, including AI, biotechnology, and space technology. In 2024, Draper Cygnus participated in a Seed Round for Ayuvant, a company that likely operates within the biotechnology space, showcasing their active engagement in this industry. Additionally, they have made investments in other startups like Panarum and ArgenTag, which, while not explicitly stated as biotechnology companies, reflect their overall strategy of supporting innovative technology ventures. Their mission is to empower Latino founders and reshape the future through deep-tech innovation, which includes a focus on biotechnology.

14. DNA Capital

• Website: dnacapital.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: dna-capital-br

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support for growth and innovation in the healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Notably, they have invested in biotechnology companies such as Spotlight Therapeutics, which raised $30 million in a Series A round in November 2020, and Cambridge Epigenetix, which raised $30 million in a Series C round in September 2018. These investments highlight DNA Capital's commitment to fostering innovation in the biotechnology field.

15. Fen Ventures

• Website: fenventures.com
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn: fen-ventures

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within the Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. Notably, Fen Ventures has made significant investments in the biotechnology space, including a $2.5 million seed round for Xeptiva Therapeutics and participation in a $2.1 million investment round for Bioeutectics, which focuses on green solvents. Additionally, they were involved in the seed funding round for Michroma, a company that has raised a total of $7.4 million in venture capital. These transactions highlight Fen Ventures' commitment to fostering innovation in biotechnology alongside their broader investment strategy.

16. Ecoa Capital

• Website: ecoacapital.com
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

Ecoa Capital is a corporate investment firm based in Sao Paulo, Brazil, founded in 2021. The firm is dedicated to creating social, environmental, and economic value through strategic partnerships and investments in sustainable businesses. Ecoa Capital operates across multiple sectors, including food supply, urban systems, and health. Notably, they have participated in significant transactions in the health sector, such as their investment in Symbiomics, which raised $2,152,937 in a seed round in January 2023 and an undisclosed amount in a venture round in December 2023. Additionally, they were involved in a Series A funding round for Nintx, which raised $10 million in December 2024. These transactions highlight Ecoa Capital's active role in supporting health-related innovations, aligning with the biotechnology industry's objectives.

17. big_bets

• Website: bigbets.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investment and consulting for technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets participated in significant transactions within the biotechnology sector, including a seed round for Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which also raised an undisclosed amount in a seed round. These investments highlight big_bets' commitment to supporting innovative companies in the biotechnology space, alongside their broader focus on technology startups.

18. Aurus

• Website: aurus.cl
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: aurus

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in multiple funding rounds for Andes Biotechnologies, a company focused on biotechnology, with investments spanning from 2010 to 2014, including Series A and Series B rounds. This track record in the biotechnology sector highlights Aurus's capability and interest in supporting innovative companies within this industry.

Biotechnology Insights: Key Investors in Latin America

Want to find more investors focusing on the biotechnology industry?

With Inven, you'll also get to know:

• Deal History: Number of deals and their sizes.
• Portfolio: Companies they've invested in.
• Contact data: Key dealmakers, including their emails and phonenumbers.
• ...and much more!